MarketPulse
S

$SRPT

3 articles found
2 positive
1 negative
0 neutral
The Motley FoolThe Motley Fool··Jeff Siegel

Three Biotech Plays Emerge as FDA Activity, Rate Stability Drive Sector Interest

Biotech stocks $SDGR, $SRPT, and $NRXP gain attention as FDA activity accelerates and interest rates stabilize, offering varied risk-reward profiles.
NRXPNRXPWSRPTSDGRFDA approvalgene therapy
GlobeNewswire Inc.GlobeNewswire Inc.··Bcc Research

Protein Synthesis Research Market Projected to Double to $42.8B by 2031

Global protein synthesis research market expected to reach $42.8 billion by 2031, driven by surging cell and gene therapy investment and government support.
NVSAZNTMOLZAGYBIIB+6cell and gene therapybiotechnology
BenzingaBenzinga··Piero Cingari

Nasdaq 100 Enters Correction as 30-Year Yields Approach 5% Milestone

Nasdaq 100 enters correction territory down 10% from January highs as 30-year Treasury yields near 5% and Fed rate hike odds spike to 50%.
METAGDXFOURFOURpAXLE+14inflationsector rotation